Home/Subscribe/Services
  • Home Page
  • Subscribe to Psychopharmacology Bulletin on-line
  • CME on demand: Independent CME for Practitioners
  • Editorial Advisory Board
  • Author's Guidelines
  • Brief Bulletins from the Field, V. 41, N. 2, 2008
  •  
  • RECENT SUBMISSIONS TO PSYCHOPHARMACOLOGY BULLETIN
  • Psychopharmacology Bulletin: Fast Facts
Enduring Materials: Indexed by Category
  • Original Research
  • Drug Disposition & Pharmacokinetics
  • Evidence-Based Medicine
  • Complicated Case Histories
  • Negative & Failed Clinical Trial Reports
  • General Psychiatry
  • Translational Neuroscience
  • Brain Imaging
  • —  Psychiatric Comorbidities
  • Review Articles
  • Letters to the Editor
Enduring Materials: Miscellaneous
  • Scientific Reprints
  • Assessment & Diagnostic Rating Scales
  • Scientific Articles & Editorials
  • Articles from our Spanish Journal
  • Clinical Reference Guides: Tools you can use
  • Patient/Physician Resource Guides
News of the Day
  • FDA Warns About Naltrexone Injection Site
  • Na'l Academy: anthrax vaccine ups psych illness
  • Study: Physical Fitness = Less Alzheimer's Disease
  • AstraZeneca Submits Seroquel XR in Europe for MDD
  • FDA Approves Vyvanse for Use in Adults
  • Abilify Receives Expanded Indications
  • Outcomes to Measure Clinical Trials in Children
  • Stimulant Improves Sleep in Adults With ADHD
  • New Link: Down's Syndrome and Alzheimer's Disease
  • Vagal Nerve Stimulation for Depression
  • Pristiq, Wyeth Antidepressant, Approved by FDA
  • Antidepressants for the Treatment of Chronic Pain
  • FDA Accepts NDA of Milnacipran for Fibromyalgia
  • Assessing Suicide Risk in Bipolar Patients
  • Metformin Effective in Antipsychotic Weight Gain
  • Double Relapse Rates for Pregnant Bipolar Patients
General Information
  • MedWorks' Other Titles
  •  
  • Contact Us
  • Editor's Login
Search Engine
  • Useful Links
    • MedWorks Media
    • Medscape WebMD CME
    • National Library of Medicine
    • Medline/Pubmed
    • Centerwatch Clinical Trials
    • FDA Website Index
    • APA Calendar
    • Bioethics Web Log
    • NIMH Home Page
    • health4care
    • In the Pipeline
    • The Carlat Psychiatry Blog
    • Furious Seasons
  • Of  Interest
    • Economics of Scientific and Biomedical Journals
    • Psychiatry Best Evidence Powered by McMaster Plus

brainscienceblogs.com

New Medicine Brought to Life by the World's Top Researchers

Psychiatric Comorbidities

Cholesterol-Lowering Medication and Relapse of Depression
By David C. Steffens,MD, MHS, Douglas R. McQuoid, BS, and K. Ranga Rama Krishnan, MB, ChB
Posted on Tuesday, March 25, 2008 at 02:53PM by Registered CommenterContacts in Psychiatric Comorbidities | CommentsPost a Comment
Copyright © 2008, MedWorks Media Global. All rights reserved.